Equinix CHF 300 million bond offering
We advised Equinix on a Regulation S bond offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
AN2 Therapeutics $70 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Monitronics International emerges from chapter 11
We advised the ad hoc lender group that negotiated and backstopped the restructuring
Nextracker $662.5 million common stock offering
We advised Nextracker on the SEC-registered secondary offering
Lucid Group $232 million strategic supply agreement with Aston Martin
We are advising Lucid Group on the transaction
Lucid $3 billion public offering of stock and concurrent private placement
We advised Lucid on the transactions
Texas Instruments $1.6 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Monitronics International chapter 11 filing and DIP financing
We are advising the ad hoc lender group that is backstopping the restructuring
Enovix $162.5 million convertible senior notes and capped call transactions
The 3.00% convertible notes are due 2028